SCINTIX Therapy SCINTIX Therapy Leverages Breakthrough Device Status to Garner Accretive New Technology Reimbursement November 22, 2024
SCINTIX Therapy SCINTIX Therapy Leverages Breakthrough Device Status to Garner Accretive New Technology Reimbursement
BgRT Presentations at ASTRO 2021 Highlight RefleXion’s X1 as a New Modality With the Potential to Treat All Stages of Cancer
BgRT New Scientific Advisory Board Will Help RefleXion Advance Multidisciplinary Cancer Care and Metastatic Cancer Treatment
BgRT City of Hope Purchases RefleXion’s X1 and Signs Collaboration Agreement to Offer Novel Clinical Trials to Test BgRT*
RefleXion X1 RefleXion Combination Therapy: Crossing the Divide with Biology-guided Radiotherapy to Treat the Untreatable